Final answer:
Blocking histone deacetylases leads to increased histone acetylation, which relaxes chromatin structure and promotes gene expression. This mechanism can be utilized to reactivate silenced tumor suppressor genes in cancer cells and thereby inhibit cancer progression. Understanding gene expression in cancer cells aids in identifying therapeutic targets and understanding the behavior of the cancer.
Step-by-step explanation:
Blocking histone deacetylases affects gene expression by increasing the acetylation levels of histones. This acetylation unwinds nucleosomes and allows for the underlying DNA to be more transcriptionally active. In the context of cancer, such inhibitors can reactivate genes that have been silenced by epigenetic modifications, thereby disrupting the abnormal growth patterns of tumor cells. By changing the epigenetic landscape, histone deacetylase inhibitors can help to switch back on tumor suppressor genes or other genes that contribute to the re-establishment of normal cellular growth patterns and apoptosis, potentially aiding in the treatment of cancer.
Understanding the gene expression in a cancer cell provides key insights into the specific type of cancer. By analyzing which genes are overexpressed or silenced, researchers can identify potential targets for therapy and better understand the cancer's growth and metastatic behavior. New drugs designed to target epigenetic alterations can thus capitalize on these insights to develop more effective treatment strategies that reprogram cancer cells to cease their uncontrolled growth or to undergo programmed cell death.